Anti-Helicobacter pylori Activity of Isocoumarin Paepalantine: Morphological and Molecular Docking Analysis

Abstract

The <i>Helicobacter</i><i>pylori</i> bacterium is one of the main causes of chronic gastritis, peptic ulcers, and even gastric cancer. It affects an average of half of the world population. Its difficult eradication depends upon multi-drug therapy. Since its classification as a group 1 carcinogenic by International Agency for Research on Cancer (IARC), the importance of <i>H. pylori</i> eradication has obtained a novel meaning. There is considerable interest in alternative therapies for the eradication of <i>H. pylori</i> using compounds from a wide range of natural products. In the present study, we investigated the antibacterial property of the isocoumarin paepalantine against <i>H. pylori</i> and it exhibited significant anti-<i>H. pylori</i> activity at a minimum inhibitory concentration (MIC) of 128 μg/mL and at a minimum bactericidal concentration (MBC) of 256 μg/mL. The scanning electron microscopy (SEM) revealed significant morphological changes of the bacterial cell as a response to a sub-MIC of paepalantine, suggesting a penicillin-binding protein (PBP) inhibition. Computational studies were carried out in order to study binding modes for paepalantine in PBP binding sites, exploring the active and allosteric sites. The data from the present study indicates that paepalantine exhibits significant anti-<i>H. pylori</i> activity, most likely by inhibiting membrane protein synthesis.